The major 5′ end of HIV type 1 RNA corresponds to G456

AIDS Research and Human Retroviruses

Volumn 23, Issue 8, 2007, Pages 1042-1048

  Menees, Thomas M ^a   Müller, Barbara ^b   Kräusslich, Hans Georg ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYLGUANOSINE; COMPLEMENTARY DNA; CYTOSINE; RNA LIGASE; VIRUS DNA; VIRUS RNA; OLIGORIBONUCLEOTIDE;

ARTICLE; DNA SEQUENCE; GENE AMPLIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RNA STRUCTURE; VIRION; VIRUS TYPING; CHEMISTRY; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; VIROLOGY;

BASE SEQUENCE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; OLIGORIBONUCLEOTIDES; RNA, VIRAL;

EID: 34848830785     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0275     Document Type: Article

References (38)

1. Cheng Z and Menees TM: RNA branching and debranching in the yeast retrovirus-like element Ty1. Science 2004;303:240-243.
2. Goff SP: Retroviridae: The retroviruses and their replication. In: Fields Virology, Vol. 2, 4th ed. (Knipe DM and Howley PM, Eds.). Lipincott, Williams & Wilkins, Philadelphia, 2001, pp. 1871-1939.
3. Ye Y, De Leon J, Yokoyama N, Naidu Y, and Camerini D: DBR1 siRNA inhibition of HIV-1 replication. Retrovirology 2005;2:63.
4. Cougot N, van Dijk E, Babajko S, and Seraphin B: 'Cap-tabolism'. Trends Biochem Sci 2004;29:436-444.
5. Peterlin BM and Price DH: Controlling the elongation phase of transcription with P-TEFb. Mol Cell 2006;23:297-305.
6. Shuman S: Structure, mechanism, and evolution of the mRNA capping apparatus. Prog Nucleic Acid Res Mol Biol 2001;66:1-40.
7. Schwer B, Mao X, and Shuman S: Accelerated mRNA decay in conditional mutants of yeast mRNA capping enzyme. Nucleic Acids Res 1998;26:2050-2057.
8. Reddy R, Ro-Choi TS, Henning D, and Busch H: Primary sequence of U-1 nuclear ribonucleic acid of Novikoff hepatoma ascites cells. J Biol Chem 1974;249:6486-6494.
9. Banerjee AK: 5′-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev 1980;44:175-205.
10. Keith J and Fraenkel-Conrat H: Identification of the 5′ end of Rous sarcoma virus RNA. Proc Natl Acad Sci USA 1975;72:3347-3350.
11. Furuichi Y, Shatkin AJ, Stavnezer E, and Bishop JM: Blocked, methylated 5′-terminal sequence in avian sarcoma virus RNA. Nature 1975;257:618-620.
12. Zhou M, Deng L, Kashanchi F, Brady JN, Shatkin AJ, and Kumar A: The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc Natl Acad Sci USA 2003;100:12666-12671.
13. Chiu YL, Coronel E, Ho CK, Shuman S, and Rana TM: HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA. J Biol Chem 2001;276:12959-12966.
14. Chiu YL, Ho CK, Saha N, Schwer B, Shuman S, and Rana TM: Tat stimulates cotranscriptional capping of HIV mRNA. Mol Cell 2002;10:585-597.
15. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59:284-291.
16. Starcich B, Ratner L, Josephs SF, Okamoto T, Gallo RC, and Wong-Staal F: Characterization of long terminal repeat sequences of HTLV-III. Science 1985;227:538-540.
17. Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, and Capon DJ: Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 1985;313:450-458.
18. Welker R, Hohenberg H, Tessmer U, Huckhagel C, and Krausslich HG: Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol 2000;74:1168-1177.
19. Volloch V, Schweitzer B, and Rits S: Ligation-mediated amplification of RNA from murine erythroid cells reveals a novel class of beta globin mRNA with an extended 5′-untranslated region. Nucleic Acids Res 1994;22:2507-2511.
20. Maruyama K and Sugano S: Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 1994;138:171-174.
21. Schaefer BC: Revolutions in rapid amplification of cDNA ends: New strategies for polymerase chain reaction cloning of full-length cDNA ends. Anal Biochem 1995;227:255-273.
22. Frohman M: Rapid amplification of cDNA ends. In: PCR Primer: A Laboratory Manual (Dieffenbach C and Dveksler G, Eds.). Cold
23. Spring Harbor Laboratory Press, Plainview, NY, 1995, pp. 381-409.
24. Schwartz DE, Zamecnik PC, and Weith HL: Rous sarcoma virus genome is terminally redundant: The 3′ sequence. Proc Natl Acad Sci USA 1977;74:994-998.
25. Ben-Artzi H, Zeelon E, Amit B, Wortzel A, Gorecki M, and Panet A: RNase H activity of reverse transcriptases on substrates derived from the 5′ end of retroviral genome. J Biol Chem 1993;268: 16465-16471.
26. Ben-Artzi H, Shemesh J, Zeelon E, Amit B, Kleiman L, Gorecki M, and Panet A: Molecular analysis of the second template switch during reverse transcription of the HIV RNA template. Biochemistry 1996;35:10549-10557.
27. Gotte M, Fackler S, Hermann T, Perola E, Cellai L, Gross HJ, Le Grice SF, and Heumann H: HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: Implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA. EMBO J 1995;14:833-841.
28. Schultz SJ, Whiting SH, and Champoux JJ: Cleavage specificities of Moloney murine leukemia virus RNase H implicated in the second strand transfer during reverse transcription. J Biol Chem 1995;270:24135-24145.
29. Mules EH, Uzun O, and Gabriel A: Replication errors during in vivo Ty1 transposition are linked to heterogeneous RNase H cleavage sites. Mol Cell Biol 1998;18:1094-1104.
30. Ben-Artzi H, Zeelon E, Gorecki M, and Panet A: Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci USA 1992;89:927-931.
31. Ben-Artzi H, Zeelon E, Le-Grice SF, Gorecki M, and Panet A: Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases. Nucleic Acids Res 1992;20:5115-5118.
32. Davison AJ and Moss B: Structure of vaccinia virus early promoters. J Mol Biol 1989;210:749-769.
33. Hirzmann J, Luo D, Hahnen J, and Hobom G: Determination of messenger RNA 5′-ends by reverse transcription of the cap structure. Nucleic Acids Res 1993;21:3597-3598.
34. Volloch VZ, Schweitzer B, and Rits S: Transcription of the 5′-terminal cap nucleotide by RNA-dependent DNA polymerase: Possible involvement in retroviral reverse transcription. DNA Cell Biol 1995;14:991-996.
35. Lanciault C and Champoux JJ: Effects of unpaired nucleotides within HIV-1 genomic secondary structures on pausing and strand transfer. J Biol Chem 2005;280:2413-2423.
36. Chen Y, Balakrishnan M, Roques BP, Fay PJ, and Bambara RA: Mechanism of minus strand strong stop transfer in HIV-1 reverse transcription. J Biol Chem 2003;278:8006-8017.
37. Goldschmidt V, Didierjean J, Ehresmann B, Ehresmann C, Isel C, and Marquet R: Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance. Nucleic Acids Res 2006;34:42-52.
38. Kasprzak W, Bindewald E, and Shapiro BA: Structural polymorphism of the HIV-1 leader region explored by computational methods. Nucleic Acids Res 2005;33:7151-7163.